Glucagon-like peptide-1 receptor agonists for type 2 diabetes


While there are several drug classes available for treating type 2 diabetes, the glucagon-like peptide-1 (GLP-1) receptor agonists are one of the newer classes of pharmacological agents. By Carrie Stewart, pharmacist diabetes educator Learning Objectives After completing this activity pharmacists should be able to: describe the pharmacology and pathophysiology of GLP-1 receptor agonists; discuss where

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?